Reuters logo
BRIEF-Bellerophon reports Q2 loss per share $0.12
August 7, 2017 / 1:18 PM / 4 months ago

BRIEF-Bellerophon reports Q2 loss per share $0.12

Aug 7 (Reuters) - Bellerophon Therapeutics Inc

* Bellerophon reports second quarter 2017 financial results and provides business update

* Q2 loss per share $0.12

* Bellerophon Therapeutics - Anticipate reporting top line results for inovation-1 phase 3 trial in PAH in 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below